Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

Colombian grower gets export license for European markets

Pideka, a wholly owned subsidiary of Ikänik Farms, has been issued Good Manufacturing Practices-PHARMA certification for its Casa Flores cannabis camp in Colombia, currently under construction. The GMP-PHARMA certification was issued by SGS Colombia.

With this new certification, Pideka will have the ability to export pharmaceutical grade finished cannabis extract products to European markets from its state-of-the-art Casa Flores camp. Casa Flores is the first cannabis manufacturing facility in Colombia to receive GMP-PHARMA certification for both its cultivation and manufacturing facility.

"Our team has worked extremely hard in Colombia to advance our overall mission. And we're nearing an inflection point that will open us up to European markets. Receiving the GMP-PHARMA certification continues to reflect the company's focus on excellence", said Borja Sanz de Madrid, President of Ikänik Farms International, Inc.

"The GMP PHARMA certification continues to demonstrate the commitment to quality and controls implemented at our Casa Flores facility, to supply international market with pharmaceutical grade cannabis," said Brian Baca, CEO of Ikänik Farms.

For more information:
Ikänik International
ikanikfarms.com

Publication date: